Genentech Herceptin MDL Created, Sent To Judge Kern In Oklahoma
WASHINGTON, D.C. — Nine federal lawsuits alleging breach-of-warranty claims against Genentech Inc. for allegedly shorting vials of the breast cancer drug Herceptin were centralized April 7 in the U.S. District Court...To view the full article, register now.
Already a subscriber? Click here to view full article